No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg

REGISTER for free or LOG IN to view this content

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

We Recommend